Multicenter phase II trial evaluating a three-weekly schedule of irinotecan plus raltitrexed in patients with 5-fluorouracil-refractory advanced colorectal cancer (Q44508390)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter phase II trial evaluating a three-weekly schedule of irinotecan plus raltitrexed in patients with 5-fluorouracil-refractory advanced colorectal cancer |
scientific article |
Statements
1 reference
Multicenter phase II trial evaluating a three-weekly schedule of irinotecan plus raltitrexed in patients with 5-fluorouracil-refractory advanced colorectal cancer (English)
1 reference
J Aparicio
1 reference
J M Vicent
1 reference
I Maestu
1 reference
S Garcerá
1 reference
I Busquier
1 reference
C Bosch
1 reference
C Llorca
1 reference
R Díaz
1 reference
C Fernández-Martos
1 reference
A Galán
1 reference
1 July 2003
1 reference
1 reference
14
1 reference
7
1 reference
1121-1125
1 reference
Identifiers
1 reference
1 reference